Physical activity is one of the five priority interventions for the prevention of Non-Communicable Diseases (NCDs). NCDs include; cardio vascular diseases (strokes, dementia, heart disease), diabetes, chronic respiratory diseases and some Cancers. NCDs account for almost two thirds of deaths globally and are major contributors to ill-health in the elderly. Physiotherapists are well placed to enable and empower people to initiate and sustain adequate levels of physical activity as they are aware of the challenges and opportunities throughout the life span. As an invited speaker this is one of the key messages that will be conveyed at the 13th Asian Confederation of Physical Therapists in Kuala Lumpur, Malaysia 7th-8th October.
I will also have an opportunity to attend an academic conference at INTI International University aimed at strengthening ties between INTI and BU. Professor Narasimman Swaminathan (Deputy Dean – faculty of Health) and I will collaborate in a joint session for physiotherapy students to inspire their interest in public health initiatives. Professor Narasimman Swaminathan is a visiting professor in the FHSS at BU and is leading research initiatives at INTI which link closely to those in the Department of Human Sciences and Public Health at BU.
Fusion funding and HSS faculty conference funding has contributed to making this trip possible.











Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease